Healthcare -
Biotechnology - NASDAQ - US
$ 493.756
-0.384 %
$ 52.4 B
Market Cap
12.27
P/E
REGN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities REGN - Regeneron Pharmaceuticals, Inc.
-2.2 B
LAST VALUE
-47.68%
2 YEAR CAGR
-54.24%
5 YEAR CAGR
-26.53%
10 YEAR CAGR